{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T22:31:39Z","timestamp":1721601099410},"reference-count":47,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Oncol"],"DOI":"10.3892\/ijo.2019.4896","type":"journal-article","created":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T07:06:29Z","timestamp":1570431989000},"source":"Crossref","is-referenced-by-count":4,"title":["Analyses of FGFR3 and PIK3CA mutations in neuroblastomas and the effects of the corresponding inhibitors on neuroblastoma cell lines"],"prefix":"10.3892","author":[{"given":"Ourania","family":"Kostopoulou","sequence":"first","affiliation":[{"name":"Department of Oncology\u2011Pathology, Karolinska Institutet, 171 74 Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Holzhauser","sequence":"additional","affiliation":[{"name":"Department of Oncology\u2011Pathology, Karolinska Institutet, 171 74 Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birthe","family":"Lange","sequence":"additional","affiliation":[{"name":"Department of Oncology\u2011Pathology, Karolinska Institutet, 171 74 Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ohmayer","sequence":"additional","affiliation":[{"name":"Department of Oncology\u2011Pathology, Karolinska Institutet, 171 74 Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teodora","family":"Andonova","sequence":"additional","affiliation":[{"name":"Department of Women's and Children's Health, Karolinska Institutet, 171 74 Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Bersani","sequence":"additional","affiliation":[{"name":"Department of Oncology\u2011Pathology, Karolinska Institutet, 171 74 Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malin","family":"Wickstr\ufffdm","sequence":"additional","affiliation":[{"name":"Department of Women's and Children's Health, Karolinska Institutet, 171 74 Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Dalianis","sequence":"additional","affiliation":[{"name":"Department of Oncology\u2011Pathology, Karolinska Institutet, 171 74 Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,10,7]]},"reference":[{"key":"key20200713190118_b1-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1042\/BJ20101603","article-title":"Fibroblast growth factors and their receptors in cancer","volume":"437","author":"Wesche","year":"2011","journal-title":"Biochem J"},{"key":"key20200713190118_b2-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/path.4297","article-title":"Emergence of FGFR family gene fusions as therapeutic targets in a wide spectrum of solid tumours","volume":"232","author":"Parker","year":"2014","journal-title":"J Pathol"},{"key":"key20200713190118_b3-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"E248","DOI":"10.3390\/cancers10080248","article-title":"Lung cancers: Molecular characterization, clonal heterogeneity and evolution, and cancer stem cells","volume":"10","author":"Testa","year":"2018","journal-title":"Cancers (Basel)"},{"key":"key20200713190118_b4-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1158\/1535-7163.MCT-13-0482","article-title":"Concordance of genomic alterations between primary and recurrent breast cancer","volume":"13","author":"Meric-Bernstam","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"key20200713190118_b5-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"35339","DOI":"10.18632\/oncotarget.15240","article-title":"Targeted sequencing of tonsillar and base of tongue cancer and human papillomavirus positive unknown primary of the head and neck reveals prognostic effects of mutated FGFR3","volume":"8","author":"Bersani","year":"2017","journal-title":"Oncotarget"},{"key":"key20200713190118_b6-ijo-55-06-1372","first-page":"3395","article-title":"Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models","volume":"119","author":"Taylor","year":"2009","journal-title":"J Clin Invest"},{"key":"key20200713190118_b7-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12885-017-3274-9","article-title":"Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas","volume":"17","author":"Lehtinen","year":"2017","journal-title":"BMC Cancer"},{"key":"key20200713190118_b8-ijo-55-06-1372","first-page":"855","article-title":"The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma","volume":"123","author":"Parker","year":"2013","journal-title":"J Clin Invest"},{"key":"key20200713190118_b9-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.1158\/1078-0432.CCR-14-2744","article-title":"Deep sequencing in conjunction with expression and functional analyses reveals activation of FGFR1 in ewing sarcoma","volume":"21","author":"Agelopoulos","year":"2015","journal-title":"Clin Cancer Res"},{"key":"key20200713190118_b10-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1158\/1541-7786.MCR-06-0172","article-title":"PIK3CA gene mutations in pediatric and adult glioblastoma multiforme","volume":"4","author":"Gallia","year":"2006","journal-title":"Mol Cancer Res"},{"key":"key20200713190118_b11-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/pbc.24060","article-title":"Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma","volume":"58","author":"Grill","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"key20200713190118_b12-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1158\/1078-0432.CCR-11-2056","article-title":"Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways","volume":"18","author":"Shukla","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20200713190118_b13-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/1471-2407-6-177","article-title":"Mutations in PIK3CA are infrequent in neuroblastoma","volume":"6","author":"Dam","year":"2006","journal-title":"BMC Cancer"},{"key":"key20200713190118_b14-ijo-55-06-1372","first-page":"238","article-title":"EGFR, PIK3CA and PTEN gene status and their protein product expression in neuroblastic tumours","volume":"48","author":"Izycka-Swieszewska","year":"2010","journal-title":"Folia Neuropathol"},{"key":"key20200713190118_b15-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1158\/0008-5472.CAN-06-2201","article-title":"Activation of Akt predicts poor outcome in neuroblastoma","volume":"67","author":"Opel","year":"2007","journal-title":"Cancer Res"},{"key":"key20200713190118_b16-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"57525","DOI":"10.18632\/oncotarget.10544","article-title":"Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors","volume":"7","author":"Vaughan","year":"2016","journal-title":"Oncotarget"},{"key":"key20200713190118_b17-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"8139","DOI":"10.1158\/0008-5472.CAN-05-2769","article-title":"Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma","volume":"66","author":"Chesler","year":"2006","journal-title":"Cancer Res"},{"key":"key20200713190118_b18-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1002\/ijc.26268","article-title":"Effects of small molecule inhibitors of PI3K\/Akt\/mTOR signaling on neuro-blastoma growth in vitro and in vivo","volume":"129","author":"Segerstr\u00f6m","year":"2011","journal-title":"Int J Cancer"},{"key":"key20200713190118_b19-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1158\/2159-8290.CD-13-0063","article-title":"What a tangled web we weave: Emerging resistance mechanisms to inhibition of the phosphoinositide 3-kinase pathway","volume":"3","author":"Klempner","year":"2013","journal-title":"Cancer Discov"},{"key":"key20200713190118_b20-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1056\/NEJMra0804577","article-title":"Recent advances in neuroblastoma","volume":"362","author":"Maris","year":"2010","journal-title":"N Engl J Med"},{"key":"key20200713190118_b21-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrc1014","article-title":"Neuroblastoma: Biological insights into a clinical enigma","volume":"3","author":"Brodeur","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"key20200713190118_b22-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"e8239","DOI":"10.1371\/journal.pone.0008239","article-title":"DNA from KI, WU and Merkel cell polyomaviruses is not detected in childhood central nervous system tumours or neuroblastomas","volume":"4","author":"Giraud","year":"2009","journal-title":"PLoS One"},{"key":"key20200713190118_b23-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"e586","DOI":"10.1038\/cddis.2013.84","article-title":"Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma","volume":"4","author":"Kocak","year":"2013","journal-title":"Cell Death Dis"},{"key":"key20200713190118_b24-ijo-55-06-1372","first-page":"2643","article-title":"Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture","volume":"33","author":"Biedler","year":"1973","journal-title":"Cancer Res"},{"key":"key20200713190118_b25-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/jnci\/57.3.683","article-title":"A novel chromosome abnormality in human neuroblastoma and antifolate-resistant Chines hamster cell lives in culture","volume":"57","author":"Biedler","year":"1976","journal-title":"J Natl Cancer Inst"},{"key":"key20200713190118_b26-ijo-55-06-1372","first-page":"51","article-title":"Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies","volume":"73","author":"Sugimoto","year":"1984","journal-title":"J Natl Cancer Inst"},{"key":"key20200713190118_b27-ijo-55-06-1372","first-page":"39","article-title":"Human neuroblastoma cells and 13-cis-retinoic acid","volume":"3","author":"Helson","year":"1985","journal-title":"J Neurooncol"},{"key":"key20200713190118_b28-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/0022-3468(91)90684-L","article-title":"Multidrug resistance in human neuroblastoma cells","volume":"26","author":"LaQuaglia","year":"1991","journal-title":"J Pediatr Surg"},{"key":"key20200713190118_b29-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1073\/pnas.0910684107","article-title":"High-risk neuro-blastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset","volume":"107","author":"Car\u00e9n","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713190118_b30-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/1471-2164-12-443","article-title":"Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors","volume":"12","author":"Kryh","year":"2011","journal-title":"BMC Genomics"},{"key":"key20200713190118_b31-ijo-55-06-1372","first-page":"1037","article-title":"Reversion of p-glycoprotein mediated multidrug-resistance to vincristine and adriamycin by psc-833, a cyclosporine derivative in human neuroblastoma cell-lines","volume":"5","author":"Helson","year":"1994","journal-title":"Int J Oncol"},{"key":"key20200713190118_b32-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.21873\/anticanres.12774","article-title":"Overexpression of FGFR3 in HPV-positive tonsillar and base of tongue cancer is correlated to outcome","volume":"38","author":"Bersani","year":"2018","journal-title":"Anticancer Res"},{"key":"key20200713190118_b33-ijo-55-06-1372","article-title":"Antitumor effects in vitro of FGFR and PI3K inhibitors on human papillomavirus positive and negative tonsillar and base of tongue cancer","author":"Holzhauser","journal-title":"Oncol Lett"},{"key":"key20200713190118_b34-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"e00149","DOI":"10.1002\/prp2.149","article-title":"Analysis of drug combinations: Current methodological landscape","volume":"3","author":"Foucquier","year":"2015","journal-title":"Pharmacol Res Perspect"},{"key":"key20200713190118_b35-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"key":"key20200713190118_b36-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"24252","DOI":"10.18632\/oncotarget.8132","article-title":"Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use","volume":"7","author":"Patani","year":"2016","journal-title":"Oncotarget"},{"key":"key20200713190118_b37-ijo-55-06-1372","first-page":"1279","article-title":"FGFR3-related hypochondroplasia: Longitudinal growth in 57 children with the p. Asn540Lys mutation","volume":"31","author":"Arenas","year":"2018","journal-title":"J Pediatr Endocrinol Metab"},{"key":"key20200713190118_b38-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.gene.2017.10.062","article-title":"Identification of a novel mutation in the FGFR3 gene in a Chinese family with Hypochondroplasia","volume":"641","author":"Chen","year":"2018","journal-title":"Gene"},{"key":"key20200713190118_b39-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.eururo.2017.01.021","article-title":"A functional genetic screen identifies the phosphinositide 3-kinase pathway as a determinant of resistance to fibroblast grown factor receptor inhibitors in FGFR mutant urothelial cell carcinoma","volume":"71","author":"Wang","year":"2017","journal-title":"Eur Urol"},{"key":"key20200713190118_b40-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1038\/onc.2014.161","article-title":"Ligand-associated ERBB2\/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells","volume":"34","author":"Wang","year":"2015","journal-title":"Oncogene"},{"key":"key20200713190118_b41-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1158\/2159-8290.CD-12-0569","article-title":"Parallel RNA interference screens identify EGFR activation as an escape mechanism in FGFR3-mutant cancer","volume":"3","author":"Herrera-Abreu","year":"2013","journal-title":"Cancer Discov"},{"key":"key20200713190118_b42-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.3892\/or.2017.5801","article-title":"Targeting VEGFR and FGFR in head and neck squamous cell carcinoma in vitro","volume":"38","author":"Brands","year":"2017","journal-title":"Oncol Rep"},{"key":"key20200713190118_b43-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1158\/0008-5472.CAN-15-0509","article-title":"Kinome RNAi screens reveal synergistic targeting of MTOR and FGFR1 pathways for treatment of lung cancer and HNSCC","volume":"75","author":"Singleton","year":"2015","journal-title":"Cancer Res"},{"key":"key20200713190118_b44-ijo-55-06-1372","first-page":"1616","article-title":"Combined inhibition of FGFR and mTOR pathways is effective in suppressing ovarian cancer","volume":"11","author":"Cai","year":"2019","journal-title":"Am J Transl Res"},{"key":"key20200713190118_b45-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1158\/1078-0432.CCR-15-1665","article-title":"First-in-human phase I study of GSK2126458, an oral pan-class I phosphatidylinositol-3-kinase inhibitor, in patients with advanced solid tumor malignancies","volume":"22","author":"Munster","year":"2016","journal-title":"Clin Cancer Res"},{"key":"key20200713190118_b46-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41389-017-0018-2","article-title":"Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions","volume":"7","author":"Tamura","year":"2018","journal-title":"Oncogenesis"},{"key":"key20200713190118_b47-ijo-55-06-1372","doi-asserted-by":"publisher","first-page":"e740","DOI":"10.1038\/cddis.2013.264","article-title":"Differential effect of long-term drug selection with doxorubicin and vorinostat on neuroblastoma cells with cancer stem cell characteristics","volume":"4","author":"Zheng","year":"2013","journal-title":"Cell Death Dis"}],"container-title":["International Journal of Oncology"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:06:35Z","timestamp":1594667195000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijo.2019.4896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,7]]},"references-count":47,"URL":"https:\/\/doi.org\/10.3892\/ijo.2019.4896","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,7]]}}}